Dyne Therapeutics, Inc.

NASDAQ:DYN

Biotechnology

Healthcare
$16.03 +1.97%

+$0.38 today

Market cap
$3.00B
Beta
1.08
P/E (TTM)
-7.2
EPS (TTM)
-$2.74
52W Low $8.06High $25.00

Volume 2.44M

Average 1.71M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$468.18M

FY 2025 · Annual

Net Income

-$446.21M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue002.46M2.24M2.05M
Gross Profit00(2.46M)(2.24M)(2.05M)
Gross Margin—————
Research & Development121.31M142.76M210.76M281.41M398.33M
Selling, General & Admin28.72M28.2M31.4M62.48M69.85M
Operating Expenses150.03M170.96M239.7M341.64M466.14M
Depreciation & Amortization1.09M1.68M1.67M1.67M2.05M
EBITDA(148.2M)(163.5M)(234.26M)(315.75M)(437.97M)
EBITDA Margin—————
Operating Income(150.03M)(170.96M)(242.16M)(343.89M)(468.18M)
Operating Margin—————
Interest Income742K2.92M7.64M26.92M29.86M
Interest Expense02.92M006.19M
Other Income / Expenses734K2.86M6.23M26.47M21.97M
Income Before Tax(149.29M)(168.1M)(235.94M)(317.42M)(446.21M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(149.29M)(168.1M)(235.94M)(317.42M)(446.21M)
Net Margin—————
EPS (Basic)(2.93)(3.23)(3.95)(3.37)(3.47)
EPS (Diluted)(2.93)(3.23)(3.95)(3.37)(3.47)
Weighted Avg Shares50.9M51.98M59.68M94.14M128.44M
Weighted Avg Shares (Diluted)50.9M51.98M59.68M94.14M128.44M

DYN Earnings Waterfall · TTM

NASDAQ:DYN · Revenue to Net Income

Key Ratios

EPS$-3.33
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-5.5
P/S Ratio0.0

Analysis

$0 of revenue converted into -$519.4M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-3.33, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 5, 2026
8-KCurrent reportNov 5, 2026
4Statement of changes in beneficial ownershipOct 22, 2026
4Statement of changes in beneficial ownershipOct 6, 2026
8-KCurrent reportSep 29, 2026

How much revenue does DYN generate?

Dyne Therapeutics, Inc. (DYN) reported $0.00 of revenue in fiscal 2025.

Is DYN profitable?

Dyne Therapeutics, Inc. (DYN) reported -$446.21M of net income.